FEMY
Femasys Inc.
Medical - Instruments & Supplies
Market Cap$13M
5Y Perf.-94.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
FEMY vs XWEL
Revenue, margins, valuation, and 5-year total return — side by side.
XWEL
XWELL, Inc.
Personal Products & Services
Market Cap$7M
5Y Perf.-95.2%
FEMY vs XWEL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | FEMY | XWEL |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Personal Products & Services |
| Market Cap | $13M | $7M |
| Revenue (TTM) | $2M | $29M |
| Net Income (TTM) | $-19M | $-17M |
| Gross Margin | 62.0% | 22.7% |
| Operating Margin | -7.7% | -32.0% |
| Total Debt | $5M | $12M |
| Cash & Equiv. | $9M | $3M |
FEMY vs XWEL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
FEMY
XWEL
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Femasys Inc. (FEMY) | 100 | 5.3 | -94.7% |
| XWELL, Inc. (XWEL) | 100 | 4.8 | -95.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FEMY vs XWEL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: XWEL leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Femasys Inc. is the stronger pick specifically for growth and revenue expansion. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
FEMY
Femasys Inc.
The Growth Play
FEMY is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 40.8%, EPS growth 44.0%, 3Y rev CAGR 23.9%
- -96.3% 10Y total return vs XWEL's -100.0%
- 40.8% revenue growth vs XWEL's -13.8%
Best for: growth exposure and long-term compounding
XWEL
XWELL, Inc.
The Income Pick
XWEL carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.88, yield 3.8%
- Lower volatility, beta 0.88, current ratio 0.46x
- Beta 0.88, yield 3.8%, current ratio 0.46x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | FEMY | 40.8% revenue growth vs XWEL's -13.8% |
| Quality / Margins | XWEL | -58.2% margin vs FEMY's -8.1% |
| Stability / Safety | XWEL | Beta 0.88 vs FEMY's 1.10 |
| Dividends | XWEL | 3.8% yield; 1-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | XWEL | +54.5% vs FEMY's -60.6% |
| Efficiency (ROA) | XWEL | -84.7% ROA vs FEMY's -116.3%, ROIC -124.8% vs -347.4% |
FEMY vs XWEL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
FEMY vs XWEL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLXWELLAGGINGFEMY
FEMYFemasys Inc.
0leads
XWELXWELL, Inc.
1leads
6 Total Categories
CATEGORYLEADERvs FEMYMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
XWEL2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XWEL is the larger business by revenue, generating $29M annually — 12.7x FEMY's $2M. Profitability is closely matched — net margins range from -58.2% (XWEL) to -8.1% (FEMY). On growth, FEMY holds the edge at +39.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $2M | $29M |
| EBITDAEarnings before interest/tax | -$17M | -$8M |
| Net IncomeAfter-tax profit | -$19M | -$17M |
| Free Cash FlowCash after capex | -$19M | -$12M |
| Gross MarginGross profit ÷ Revenue | +62.0% | +22.7% |
| Operating MarginEBIT ÷ Revenue | -7.7% | -32.0% |
| Net MarginNet income ÷ Revenue | -8.1% | -58.2% |
| FCF MarginFCF ÷ Revenue | -8.4% | -40.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +39.9% | -4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +69.9% | -105.0% |
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Valuation Metrics
Evenly matched — FEMY and XWEL each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| Market CapShares × price | $13M | $7M |
| Enterprise ValueMkt cap + debt − cash | $9M | $17M |
| Trailing P/EPrice ÷ TTM EPS | -0.96x | -0.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 5.77x | 0.24x |
| Price / BookPrice ÷ Book value/share | 3.03x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
Evenly matched — FEMY and XWEL each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -5.3% | — |
| ROA (TTM)Return on assets | -116.3% | -84.7% |
| ROICReturn on invested capital | -3.5% | -124.8% |
| ROCEReturn on capital employed | -167.9% | -129.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 2 |
| Debt / EquityFinancial leverage | 0.80x | — |
| Net DebtTotal debt minus cash | -$5M | $10M |
| Cash & Equiv.Liquid assets | $9M | $3M |
| Total DebtShort + long-term debt | $5M | $12M |
| Interest CoverageEBIT ÷ Interest expense | -8.85x | -128.64x |
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XWEL five years ago would be worth $504 today (with dividends reinvested), compared to $374 for FEMY. Over the past 12 months, XWEL leads with a +54.5% total return vs FEMY's -60.6%. The 3-year compound annual growth rate (CAGR) favors FEMY at -15.7% vs XWEL's -37.5% — a key indicator of consistent wealth creation.
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -29.5% | +182.2% |
| 1-Year ReturnPast 12 months | -60.6% | +54.5% |
| 3-Year ReturnCumulative with dividends | -40.1% | -75.6% |
| 5-Year ReturnCumulative with dividends | -96.3% | -95.0% |
| 10-Year ReturnCumulative with dividends | -96.3% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -15.7% | -37.5% |
Evenly matched — FEMY and XWEL each lead in 3 of 6 comparable metrics.
Risk & Volatility
XWEL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
XWEL is the less volatile stock with a 0.88 beta — it tends to amplify market swings less than FEMY's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. XWEL currently trades 57.7% from its 52-week high vs FEMY's 38.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.24x | 0.88x |
| 52-Week HighHighest price in past year | $1.16 | $2.20 |
| 52-Week LowLowest price in past year | $0.31 | $0.26 |
| % of 52W HighCurrent price vs 52-week peak | +38.7% | +57.7% |
| RSI (14)Momentum oscillator 0–100 | 57.3 | 53.4 |
| Avg Volume (50D)Average daily shares traded | 513K | 2.3M |
XWEL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
XWEL is the only dividend payer here at 3.78% yield — a key consideration for income-focused portfolios.
| Metric | FEMYFemasys Inc. | XWELXWELL, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +3.8% |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | $0.05 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +25.4% |
Insufficient data to determine a leader in this category.
Key Takeaway
XWEL leads in 1 of 6 categories — strongest in Risk & Volatility. 4 categories are tied.
Best OverallXWELL, Inc. (XWEL)Leads 1 of 6 categories
Loading custom metrics...
FEMY vs XWEL: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is FEMY or XWEL a better buy right now?
For growth investors, Femasys Inc.
(FEMY) is the stronger pick with 40. 8% revenue growth year-over-year, versus -13. 8% for XWELL, Inc. (XWEL). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — FEMY or XWEL?
Over the past 5 years, XWELL, Inc.
(XWEL) delivered a total return of -95. 0%, compared to -96. 3% for Femasys Inc. (FEMY). Over 10 years, the gap is even starker: FEMY returned -96. 4% versus XWEL's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — FEMY or XWEL?
By beta (market sensitivity over 5 years), XWELL, Inc.
(XWEL) is the lower-risk stock at 0. 88β versus Femasys Inc. 's 1. 24β — meaning FEMY is approximately 41% more volatile than XWEL relative to the S&P 500.
04Which is growing faster — FEMY or XWEL?
By revenue growth (latest reported year), Femasys Inc.
(FEMY) is pulling ahead at 40. 8% versus -13. 8% for XWELL, Inc. (XWEL). On earnings-per-share growth, the picture is similar: Femasys Inc. grew EPS 44. 0% year-over-year, compared to -38. 8% for XWELL, Inc.. Over a 3-year CAGR, FEMY leads at 23. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — FEMY or XWEL?
XWELL, Inc.
(XWEL) is the more profitable company, earning -58. 2% net margin versus -812. 3% for Femasys Inc. — meaning it keeps -58. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XWEL leads at -32. 0% versus -767. 0% for FEMY. At the gross margin level — before operating expenses — FEMY leads at 62. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — FEMY or XWEL?
In this comparison, XWEL (3.
8% yield) pays a dividend. FEMY does not pay a meaningful dividend and should not be held primarily for income.
07Is FEMY or XWEL better for a retirement portfolio?
For long-horizon retirement investors, XWELL, Inc.
(XWEL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 88), 3. 8% yield). Both have compounded well over 10 years (XWEL: -100. 0%, FEMY: -96. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between FEMY and XWEL?
These companies operate in different sectors (FEMY (Healthcare) and XWEL (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FEMY is a small-cap high-growth stock; XWEL is a small-cap income-oriented stock. XWEL pays a dividend while FEMY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(FEMY: 39.9% · XWEL: -4.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.